Upper tract urinary carcinoma: a unique immuno-molecular entity and a clinical challenge in the current therapeutic scenario

G Mazzaschi, GC Giudice, M Corianò… - … in Cancer Research …, 2023 - journals.sagepub.com
Urothelial carcinoma (UC) is the most frequent malignancy of the urinary tract, which
consists of bladder cancer (BC) for 90%, while 5% to 10%, of urinary tract UC (UTUC). BC …

Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario

G Mazzaschi, GC Giudice, M Corianò… - TECHNOLOGY IN …, 2023 - air.unipr.it
: Urothelial carcinoma (UC) is the most frequent malignancy of the urinary tract, which
consists of bladder cancer (BC) for 90%, while 5% to 10%, of urinary tract UC (UTUC). BC …

[HTML][HTML] Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario

G Mazzaschi, GC Giudice, M Corianò… - Technology in Cancer …, 2023 - ncbi.nlm.nih.gov
Urothelial carcinoma (UC) is the most frequent malignancy of the urinary tract, which
consists of bladder cancer (BC) for 90%, while 5% to 10%, of urinary tract UC (UTUC). BC …

Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario.

G Mazzaschi, GC Giudice, M Corianò… - … in Cancer Research …, 2023 - search.ebscohost.com
Urothelial carcinoma (UC) is the most frequent malignancy of the urinary tract, which
consists of bladder cancer (BC) for 90%, while 5% to 10%, of urinary tract UC (UTUC). BC …

Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario

G Mazzaschi, GC Giudice… - … in cancer research …, 2023 - pubmed.ncbi.nlm.nih.gov
Urothelial carcinoma (UC) is the most frequent malignancy of the urinary tract, which
consists of bladder cancer (BC) for 90%, while 5% to 10%, of urinary tract UC (UTUC). BC …

Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario.

G Mazzaschi, GC Giudice, M Corianò… - Technology in Cancer …, 2023 - europepmc.org
Urothelial carcinoma (UC) is the most frequent malignancy of the urinary tract, which
consists of bladder cancer (BC) for 90%, while 5% to 10%, of urinary tract UC (UTUC). BC …

[PDF][PDF] Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario

MD Fabiana Perrone, MD Michele Maffezzoli… - 2023 - scienceopen.com
Urothelial carcinoma (UC) is the most frequent malignancy of the urinary tract, which
consists of bladder cancer (BC) for 90%, while 5% to 10%, of urinary tract UC (UTUC). BC …

Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario.

G Mazzaschi, GC Giudice, M Corianò… - Technology in Cancer …, 2023 - europepmc.org
Urothelial carcinoma (UC) is the most frequent malignancy of the urinary tract, which
consists of bladder cancer (BC) for 90%, while 5% to 10%, of urinary tract UC (UTUC). BC …